BIOMERICA INC (BMRA) Operating Margin
- Operating margin · 12 months: Value -119.47%; Formula and calculation Operating income / revenue. Period ending 2026-05-31..
Operating margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -119.47% | Operating income / revenue. Period ending 2026-05-31. $-5.32M ÷ $4.45M × 100 ≈ -119.47% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -5.32M USD | Operating Income (Loss) |
| Revenue | 4.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 788.00K USD | Research and Development Expense |
| Selling, general and administration | 4.89M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-05-31 | $-5.32M | $4.45M | (m) | $788.00K | $4.89M | -119.47% |
| 2026-02-28 | $-5.35M | $4.33M | (m) | $835.00K | $4.71M | -123.67% |
| 2025-11-30 | $-5.26M | $4.46M | (m) | $874.00K | $4.64M | -118.08% |
| 2025-08-31 | $-4.89M | $4.88M | (m) | $938.00K | $4.58M | -100.06% |
| 2025-05-31 | $-5.14M | $5.31M | (m) | $1.02M | $4.61M | -96.72% |
| 2025-02-28 | $-5.10M | $5.68M | (m) | $1.04M | $4.83M | -89.84% |
| 2024-11-30 | $-5.89M | $5.58M | (m) | $1.16M | $5.32M | -105.61% |
| 2024-08-31 | $-6.50M | $5.51M | (m) | $1.32M | $5.67M | -118.04% |
| 2024-05-31 | $-6.37M | $5.42M | (m) | $1.49M | $5.49M | -117.58% |
| 2024-02-29 | $-6.67M | $5.41M | (m) | $1.59M | $5.70M | -123.45% |
| 2023-11-30 | $-6.33M | $5.50M | (m) | $1.64M | $5.57M | -115.00% |
| 2023-08-31 | $-6.38M | $5.42M | (m) | $1.70M | $5.60M | -117.91% |
| 2023-05-31 | $-7.22M | $5.34M | (m) | $1.58M | $6.08M | -135.29% |
| 2023-02-28 | $-7.14M | $9.53M | (m) | $1.71M | $6.47M | -74.93% |
| 2022-11-30 | $-5.60M | $16.08M | (m) | $1.71M | $6.49M | -34.82% |
| 2022-08-31 | $-5.06M | $19.25M | (m) | $1.79M | $6.28M | -26.31% |
| 2022-05-31 | $-4.53M | $18.87M | (m) | $1.81M | $5.70M | -24.03% |
| 2022-02-28 | $-4.50M | $14.62M | (m) | $2.09M | $4.77M | -30.77% |
| 2021-11-30 | $-6.56M | $10.59M | (m) | $2.20M | $4.98M | -61.91% |
| 2021-08-31 | $-7.14M | $7.32M | (m) | $2.20M | $5.10M | -97.59% |
| 2021-05-31 | $-6.52M | $7.20M | (m) | $2.41M | $4.61M | -90.60% |
| 2021-02-28 | $-5.50M | $8.87M | (m) | $2.49M | $4.26M | -62.06% |
| 2020-11-30 | $-4.54M | $6.42M | (m) | $2.40M | $3.63M | -70.72% |
| 2020-08-31 | $-3.55M | $6.64M | (m) | $2.21M | $2.93M | -53.44% |
| 2020-05-31 | $-2.40M | $6.69M | (m) | $1.91M | $2.27M | -35.90% |
| 2020-02-29 | $-2.68M | $5.13M | (m) | $1.66M | $2.25M | -52.20% |
| 2019-11-30 | $-2.47M | $5.22M | (m) | $1.68M | $2.17M | -47.38% |
| 2019-08-31 | $-2.47M | $5.12M | (m) | $1.66M | $2.13M | -48.17% |
| 2019-05-31 | $-2.41M | $5.20M | (m) | $1.68M | $2.03M | -46.39% |
| 2019-02-28 | $-2.29M | $5.17M | (m) | $1.75M | $1.92M | -44.38% |
| 2018-11-30 | $-1.91M | $5.28M | (m) | $1.61M | $1.78M | -36.13% |
| 2018-08-31 | $-1.71M | $5.39M | (m) | $1.50M | $1.79M | -31.72% |
| 2018-05-31 | $-1.48M | $5.56M | (m) | $1.40M | $1.84M | -26.63% |
| 2018-02-28 | $-1.19M | $5.88M | (m) | $1.26M | $1.85M | -20.21% |
| 2017-11-30 | $-1.18M | $6.01M | (m) | $1.17M | $1.93M | -19.71% |
| 2017-08-31 | $-1.12M | $5.83M | (m) | $1.19M | $1.88M | -19.14% |
| 2017-05-31 | $-954.63K | $5.79M | (m) | $1.13M | $1.85M | -16.48% |
| 2017-02-28 | $-875.02K | $5.67M | (m) | $988.79K | $1.82M | -15.44% |
| 2016-11-30 | $-826.41K | $5.53M | (m) | $917.34K | $1.73M | -14.94% |
| 2016-08-31 | $-816.35K | $5.26M | (m) | $846.59K | $1.65M | -15.51% |
| 2016-05-31 | $-826.95K | $5.14M | (m) | $780.33K | $1.57M | -16.09% |
| 2016-02-29 | $-616.20K | $5.31M | (m) | $744.69K | $1.52M | -11.61% |
| 2015-11-30 | $-482.63K | $5.25M | (m) | $744.05K | $1.50M | -9.20% |
| 2015-08-31 | $-522.72K | $5.21M | (m) | $695.93K | $1.48M | -10.02% |
| 2015-05-31 | $-670.60K | $4.96M | (m) | $733.64K | $1.48M | -13.51% |
| 2015-02-28 | $-667.50K | $5.15M | (m) | $784.06K | $1.53M | -12.97% |
| 2014-11-30 | $-499.30K | $5.34M | (m) | $739.61K | $1.53M | -9.35% |
| 2014-08-31 | $-496.94K | $5.14M | (m) | $694.32K | $1.52M | -9.67% |
| 2014-05-31 | $-446.59K | $5.12M | (m) | $589.87K | $1.53M | -8.72% |
| 2014-02-28 | $-370.90K | $4.91M | (m) | $473.40K | $1.47M | -7.55% |
| 2013-11-30 | $-466.91K | $4.84M | (m) | $483.41K | $1.43M | -9.66% |
| 2013-08-31 | $28.09K | $5.78M | (m) | $462.36K | $1.47M | 0.49% |
| 2013-05-31 | $514.01K | $6.47M | (m) | $459.09K | $1.45M | 7.94% |
| 2013-02-28 | $555.83K | (m) | (m) | $434.77K | $1.50M | (m) |
| 2012-11-30 | $753.66K | (m) | (m) | $379.36K | $1.48M | (m) |
| 2012-08-31 | $700.25K | (m) | (m) | $349.17K | $1.46M | (m) |
| 2012-05-31 | $505.00K | (m) | (m) | $347.13K | $1.45M | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | $-132.26K | (m) | (m) | $420.57K | $1.24M | (m) |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |